Insulin aspart, recombinant Subcutaneous and Loteprednol and Tobramycin
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Loteprednol and Tobramycin and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: loteprednol / tobramycin ophthalmic
Brand name: Zylet
Synonyms: Loteprednol and tobramycin (ophthalmic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Loteprednol and tobramycin ophthalmic
- Insulin aspart, recombinant Subcutaneous-Loteprednol Etabonate
- Insulin aspart, recombinant Subcutaneous-Loteprednol Eye Drops
- Insulin aspart, recombinant Subcutaneous-Loteprednol Eye Drops 0.2%
- Insulin aspart, recombinant Subcutaneous-Loteprednol Eye Drops 0.5% and 1%
- Insulin aspart, recombinant Subcutaneous-Loteprednol Eye Gel
- Loteprednol and Tobramycin-Insulin degludec
- Loteprednol and Tobramycin-Insulin Degludec (U-100) Prefilled Pens
- Loteprednol and Tobramycin-Insulin Degludec (U-100) Vials
- Loteprednol and Tobramycin-Insulin Degludec (U-200) Prefilled Pens
- Loteprednol and Tobramycin-Insulin degludec and liraglutide
- Loteprednol and Tobramycin-Insulin degludec and liraglutide Subcutaneous